Proton magnetic resonance spectroscopy and illness stage in schizophreniaa systematic review and meta-analysis

Biological Psychiatry

Volumn 69, Issue 5, 2011, Pages 495-503

  Brugger, Stefan ^a,b   Davis, John M ^d,e   Leucht, Stefan ^f   Stone, James M ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

MRS; N acetyl aspartate (NAA); psychosis; schizophrenia; spectroscopy

Indexed keywords

N ACETYLASPARTIC ACID;

ARTICLE; BASAL GANGLION; BRAIN REGION; CEREBELLUM; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DOWN REGULATION; FRONTAL LOBE; HUMAN; META ANALYSIS; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TEMPORAL LOBE; THALAMUS;

ASPARTIC ACID; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PUBLICATION BIAS; REGRESSION ANALYSIS; RISK; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TEMPORAL LOBE; THALAMUS;

EID: 79951682529     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.10.004     Document Type: Article

References (129)

1. J.R. Moffett, B. Ross, P. Arun, C.N. Madhavarao, and A.M. Namboodiri N-acetylaspartate in the CNS: From neurodiagnostics to neurobiology Prog Neurobiol 81 2007 89 131 (Pubitemid 46282272)
2. R.G. Steen, R.M. Hamer, and J.A. Lieberman Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis Neuropsychopharmacology 30 2005 1949 1962 (Pubitemid 43093497)
3. A.R. Yung, H.P. Yuen, G. Berger, S. Francey, T.C. Hung, and B. Nelson Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 33 2007 673 681 (Pubitemid 47343718)
4. S.J. Borgwardt, A. Riecher-Rossler, P. Dazzan, X. Chitnis, J. Aston, and M. Drewe Regional gray matter volume abnormalities in the at risk mental state Biol Psychiatry 61 2007 1148 1156 (Pubitemid 46669460)
5. C. Pantelis, D. Velakoulis, P.D. McGorry, S.J. Wood, J. Suckling, and L.J. Phillips Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison Lancet 361 2003 281 288 (Pubitemid 36126187)
6. J.M. Lappin, P. Dazzan, K. Morgan, C. Morgan, X. Chitnis, and J. Suckling Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis Br J Psychiatry 51 2007 s123 s127
7. F. Jessen, H. Scherk, F. Trber, S. Theyson, J. Berning, and R. Tepest Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia Schizophr Res 87 2006 81 88 (Pubitemid 44428131)
8. D.A. Lewis, L.A. Glantz, J.N. Pierri, and R.A. Sweet Altered cortical glutamate neurotransmission in schizophrenia: Evidence from morphological studies of pyramidal neurons Ann N Y Acad Sci 1003 2003 102 112 (Pubitemid 38083048)
9. J.M. Stone, F. Day, H. Tsagaraki, I. Valli, M.A. McLean, and D.J. Lythgoe Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume Biol Psychiatry 66 2009 533 539
10. S.J. Wood, G. Berger, D. Velakoulis, L.J. Phillips, P.D. McGorry, and Yung Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals Schizophr Bull 29 2003 831 843 (Pubitemid 38181959)
11. T.N. Venkatraman, R.M. Hamer, D.O. Perkins, A.W. Song, J.A. Lieberman, and R.G. Steen Single-voxel 1H PRESS at 4.0 T: Precision and variability of measurements in anterior cingulate and hippocampus NMR Biomed 19 2006 484 491 (Pubitemid 43997767)
12. R.G. Steen, C. Mull, R. McClure, R.M. Hamer, and J.A. Lieberman Brain volume in first-episode schizophrenia: Systematic review and meta-analysis of magnetic resonance imaging studies Br J Psychiatry 188 2006 510 518 (Pubitemid 43844097)
13. C. Abbott, and J. Bustillo What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update Curr Opin Psychiatry 19 2006 135 139 (Pubitemid 44406123)
14. J.F. Jansen, W.H. Backes, K. Nicolay, and M.E. Kooi 1H MR spectroscopy of the brain: Absolute quantification of metabolites Radiology 240 2006 318 332 (Pubitemid 44098628)
15. L.J. Phillips, A.R. Yung, and P.D. McGorry Identification of young people at risk of psychosis: Validation of Personal Assessment and Crisis Evaluation Clinic intake criteria Aust N Z J Psychiatry 34 suppl 2000 S164 S169
16. R. Ihaka, and R. Gentleman R: A language for data analysis and graphics J Comput Graph Stat 5 1996 299 314
17. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
18. M. Egger, G.D. Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634 (Pubitemid 27387172)
19. S. Duval, and R. Tweedie Trim and fill: A simple funnel-plot based method of testing and adjusting for publication Bias in Meta-analysis Biometrics 56 2000 455 463 (Pubitemid 30422636)
20. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc Series B Stat Methodol 57 1995 289 300
21. A. Bertolino, J.H. Callicott, I. Elman, V.S. Mattay, G. Tedeschi, and J.A. Frank Regionally specific neuronal pathology in untreated patients with schizophrenia: A Proton Magnetic Resonance Spectroscopic Imaging Study Biol Psychiatry 43 1998 641 648 (Pubitemid 28222384)
22. K. Ando, N. Takei, H. Matsumoto, M. Iyo, H. Isoda, and N. Mori Neural damage in the lenticular nucleus linked with tardive dyskinesia in schizophrenia: A preliminary study using proton magnetic resonance spectroscopy Schizophr Res 57 2002 273 279 (Pubitemid 35240030)
23. W. Block, T.A. Bayer, R. Tepest, F. Trber, M. Rietschel, and D.J. Müller Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: A proton magnetic resonance spectroscopy study Neurosci Lett 289 2000 147 151 (Pubitemid 30440647)
24. J.R. Bustillo, J. Lauriello, L.M. Rowland, R.E. Jung, H. Petropoulos, and B.L. Hart Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia Psychiatry Res Neuroimaging 107 2001 135 149 (Pubitemid 32868799)
25. J.R. Bustillo, J. Lauriello, L.M. Rowland, L.M. Thomson, H. Petropoulos, and R. Hammond Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure Schizophr Res 58 2002 313 321 (Pubitemid 35284523)
26. J.R. Bustillo, L.M. Rowland, R. Jung, W.M. Brooks, C. Qualls, and R. Hammond Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia Neuropsychopharmacology 33 2007 2456 2466
27. G. Ende, D.F. Braus, S. Walter, W. Weber-Fahr, and F.A. Henn Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia Eur Arch Psychiatry Clin Neurosci 253 2003 9 15 (Pubitemid 37205219)
28. D. Fannon, A. Simmons, L. Tennakoon, S. O'Callaigh, A. Sumich, and V. Doku Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia Biol Psychiatry 54 2003 587 598 (Pubitemid 41115095)
29. T. Fujimoto, T. Nakano, T. Takano, K. Takeuchi, K. Yamada, and T. Fukuzako Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia Biol Psychiatry 40 1996 14 18 (Pubitemid 26191184)
30. M. Gimnez, C. Junqu, M. Prez, P. Vendrell, I. Baeza, and M. Salamero Basal ganglia N-acetylaspartate correlates with the performance in the procedural task 'Tower of Hanoi' of neuroleptic-naive schizophrenic patients Neurosci Lett 347 2003 97 100 (Pubitemid 36836225)
31. C. Heimberg, R.A. Komoroski, W.B. Lawson, D. Cardwell, and C.N. Karson Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect Psychiatry Res 83 1998 105 115 (Pubitemid 28465918)
32. T. Miyaoka, R. Yasukawa, S. Mizuno, T. Sukegawa, T. Inagaki, and J. Horiguchi Proton magnetic resonance spectroscopy (1H-MRS) of hippocampus, basal ganglia, and vermis of cerebellum in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome) J Psychiatr Res 39 2005 29 34 (Pubitemid 39422283)
33. K. Ohara, H. Isoda, Y. Suzuki, Y. Takehara, M. Ochiai, and H. Takeda Proton magnetic resonance spectroscopy of lenticular nuclei in simple schizophrenia Prog Neuro-Psychopharmacol Biol Psychiatry 24 2000 507 519 (Pubitemid 30419076)
34. J. O'Neill, J. Levitt, R. Caplan, R. Asarnow, J.T. McCracken, and A.W. Toga 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia Neuroimage 21 2004 1781 1789 (Pubitemid 38446598)
35. R. Sharma, P.N. Venkatasubramanian, M. Brny, and J.M. Davis Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients Schizophr Res 8 1992 43 49
36. T. Shioiri, H. Hamakaw, T. Kato, J. Murashita, K. Fujii, and T. Inubushi Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: A preliminary report Schizophr Res 22 1996 19 26 (Pubitemid 26352771)
37. S.Y. Tayoshi, S. Sumitani, K. Taniguchi, S. Shibuya-Tayoshi, S. Numata, and J.-i. Iga Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS) Schizophr Res 108 2009 69 77
38. H. Yamasue, T. Fukui, R. Fukuda, K. Kasai, A. Iwanami, and N. Kato Drug-induced Parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia Int J Neuropsychopharmacol 6 2003 353 360 (Pubitemid 38146253)
39. R.F. Deicken, R. Feiwell, N. Schuff, and B. Soher Evidence for altered cerebellar vermis neuronal integrity in schizophrenia Psychiatry Res Neuroimaging 107 2001 125 134 (Pubitemid 32868798)
40. G. Ende, P. Hubrich, S. Walter, W. Weber-Fahr, N. Kammerer, and D.F. Braus Further evidence for altered cerebellar neuronal integrity in schizophrenia Am J Psychiatry 162 2005 790 792 (Pubitemid 40489145)
41. P. Tibbo, C.C. Hanstock, S. Asghar, P. Silverstone, and P.S. Allen Proton magnetic resonance spectroscopy (1H-MRS) of the cerebellum in men with schizophrenia Jr Psychiatry Neuroscien Jpn 25 2000 509 512 (Pubitemid 33702244)
42. R. Bartha, P.C. Williamson, D.J. Drost, A. Malla, T.J. Carr, and L. Cortese Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy Arch Gen Psychiatry 54 1997 959 965 (Pubitemid 28022747)
43. A. Bertolino, S. Nawroz, V.S. Mattay, A.S. Barnett, J.H. Duyn, and C.T. Moonen Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging Am J Psychiatry 153 1996 1554 1563 (Pubitemid 26406165)
44. A. Bertolino, G. Esposito, J.H. Callicott, V.S. Mattay, J.D. Van Horn, and J.A. Frank Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the Working Memory Cortical Network in Schizophrenia Am J Psychiatry 157 2000 26 33 (Pubitemid 30027417)
45. A. Bertolino, A. Breier, J.H. Callicott, C. Adler, V.S. Mattay, and M. Shapiro The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia Neuropsychopharmacology 22 2000 125 132 (Pubitemid 30016014)
46. A. Bertolino, D. Sciota, F. Brudaglio, M. Altamura, G. Blasi, and A. Bellomo Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder Am J Psychiatry 160 2003 483 489 (Pubitemid 41094256)
47. W.M. Brooks, J. Hodde-Vargas, L.A. Vargas, R.A. Yeo, C.C. Ford, and R.L. Hendren Frontal lobe of children with schizophrenia spectrum disorders: A proton magnetic resonance spectroscopic study Biol Psychiatry 43 1998 263 269 (Pubitemid 28085672)
48. P.F. Buckley, C. Moore, H. Long, C. Larkin, P. Thompson, and F. Mulvany 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates Biol Psychiatry 36 1994 792 800
49. J.H. Callicott, M.F. Egan, A. Bertolino, V.S. Mattay, F.J.P. Langheim, and J.A. Frank Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: A possible intermediate neurobiological phenotype Biol Psychiatry 44 1998 941 950 (Pubitemid 28545222)
50. B.Y. Choe, K.T. Kim, T.S. Suh, C. Lee, I.H. Paik, and Y.W. Bahk 1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia Acad Radiol 1 1994 211 216
51. B.-Y.P. Choe, T.-S.P. Suh, K.-S.M. Shinn, C.-W.M. Lee, C.M. Lee, and I.-H.M. Paik Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy Investig Radiol 31 1996 345 352
52. R. Deicken, L. Zhou, F. Corwin, S. Vinogradov, and M. Weiner Decreased left frontal lobe N-acetylaspartate in schizophrenia Am J Psychiatry 154 1997 688 690 (Pubitemid 27197606)
53. P. Delamillieure, J.M. Constans, J. Fernandez, P. Brazo, and S. Dollfus Proton magnetic resonance spectroscopy (1H-MRS) of the thalamus in schizophrenia Eur Psychiatry 15 2000 489 491 (Pubitemid 32103842)
54. P. Delamillieure, J.M. Constans, J. Fernandez, P. Brazo, K. Benali, and P. Courtheoux Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: Investigation of the right and left hippocampus, thalamus, and prefrontal cortex Schizophr Bull 28 2002 329 339 (Pubitemid 35462248)
55. G. Ende, D.F. Braus, S. Walter, W. Weber-Fahr, B. Soher, and A.A. Maudsley Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia Schizophr Res 41 2000 389 395 (Pubitemid 30109595)
56. H. Fukuzako, K. Takeuchi, Y. Hokazono, T. Fukuzako, K. Yamada, and T. Hashiguchi Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: Preliminary report Psychiatry Res 61 1995 193 200
57. B. Galiska, A. Szulc, E. Tarasw, B. Kubas, W. Dzienis, and A. Czernikiewicz Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia Med Sci Monit 15 2009 CR82 CR88
58. H. Hagino, M. Suzuki, K. Mori, S. Nohara, I. Yamashita, and T. Takahashi Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: A preliminary report Psychiatry Clin Neurosci 56 2002 499 507
59. K.O. Lim, E. Adalsteinsson, D. Spielman, E.V. Sullivan, M.J. Rosenbloom, and A. Pfefferbaum Proton magnetic resonance spectroscopic imaging of cortical Gray and White matter in schizophrenia Arch Gen Psychiatry 55 1998 346 352 (Pubitemid 28173624)
60. E.S. Lutkenhoff, T.G. van Erp, M.A. Thomas, S. Therman, M. Manninen, and M.O. Huttunen Proton MRS in twin pairs discordant for schizophrenia Mol Psychiatry 15 2008 308 318 Nos.
61. V. Molina, J. Sanz, F. Sarramea, R. Luque, C. Benito, and T. Palomo No association between dorsolateral prefrontal Gray matter deficit and N-acetyl aspartate ratios in schizophrenia Neuropsychobiology 54 2006 171 178 (Pubitemid 46377228)
62. P. Ohrmann, A. Siegmund, T. Suslow, K. Spitzberg, A. Kersting, and V. Arolt Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: A proton magnetic resonance spectroscopy study Schizophr Res 73 2005 153 157 (Pubitemid 40093876)
63. P. Ohrmann, A. Siegmund, T. Suslow, A. Pedersen, K. Spitzberg, and A. Kersting Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study J Psychiatr Res 41 2007 625 634 (Pubitemid 46509646)
64. P. Ohrmann, H. Kugel, J. Bauer, A. Siegmund, K. Klkebeck, and T. Suslow Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy Schizophr Res 106 2008 156 163
65. H.M. Olbrich, G. Valerius, N. Rüsch, M. Buchert, T. Thiel, and J. Hennig Frontolimbic glutamate alterations in first episode schizophrenia: Evidence from a magnetic resonance spectroscopy study World J Biol Psychiatry 9 2008 59 63 (Pubitemid 351250521)
66. M. Omori, T. Murata, H. Kimura, Y. Koshimoto, H. Kado, and Y. Ishimori Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy Psychiatry Res Neuroimaging 98 2000 155 162 (Pubitemid 30255911)
67. D. ngür, J.E. Jensen, A.P. Prescot, C. Stork, M. Lundy, and B.M. Cohen Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania Biol Psychiatry 64 2008 718 726
68. C.U. Pae, B.Y. Choe, R.H. Joo, H.K. Lim, T.S. Kim, and S.S. Yoo Neuronal dysfunction of the frontal lobe in schizophrenia Neuropsychobiology 50 2004 211 215
69. L.M. Rowland, E.A. Spieker, A. Francis, P.B. Barker, W.T. Carpenter, and R.W. Buchanan White matter alterations in deficit schizophrenia Neuropsychopharmacology 34 2009 1514 1522
70. R.F. Sanches, J.A.S. Crippa, J.E.C. Hallak, J.P.M. de Sousa, D. Arajo, and A.C. Santos Proton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia Braz J Med Biol Res 41 2008 1132 1141
71. F. Sarramea Crespo, R. Luque, D. Prieto, P. Sau, C. Albert, and I. Leal Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder Eur Arch Psychiatry Clin Neurosci 258 2008 394 401
72. E. Shimizu, K. Hashimoto, S. Ochi, G. Fukami, M. Fujisaki, and K. Koike Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits J Psychiatr Res 41 2007 49 56 (Pubitemid 44708200)
73. T. Sigmundsson, M. Maier, B.K. Toone, S.C.R. Williams, A. Simmons, and K. Greenwood Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: A proton magnetic resonance spectroscopy study Schizophr Res 64 2003 63 71 (Pubitemid 37153350)
74. J.A. Stanley, M. Vemulapalli, J. Nutche, D.M. Montrose, J.A. Sweeney, and J.W. Pettegrew Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: A single-voxel 1H spectroscopy study Schizophr Res 93 2007 23 32 (Pubitemid 46817964)
75. R.M. Steel, M.E. Bastin, S. McConnell, I. Marshall, D.G. Cunningham-Owens, and S.M. Lawrie Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls Psychiatry Res Neuroimaging 106 2001 161 170 (Pubitemid 32520942)
76. A. Szulc, B. Galiska, E. Tarasw, B. Kubas, W. Dzienis, and B. Konarzewska N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: A proton magnetic resonance spectroscopy (1H MRS) study Med Sci Monit 13 Suppl 1 2007 17 22
77. Y. Tanaka, T. Obata, T. Sassa, E. Yoshitome, Y. Asai, and H. Ikehira Quantitative magnetic resonance spectroscopy of schizophrenia: Relationship between decreased N-acetylaspartate and frontal lobe dysfunction Psychiatry Clin Neurosci 60 2006 365 372 (Pubitemid 43736403)
78. C. Tang, J. Friedman, D. Shungu, L. Chang, T. Ernst, and D. Stewart Correlations between diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (1H MRS) in schizophrenic patients and normal controls BMC Psychiatry 7 2007 25
79. L. Tebartz van Elst, G. Valerius, M. Büchert, T. Thiel, N. Rüsch, and E. Bubl Increased prefrontal and hippocampal glutamate concentration in schizophrenia: Evidence from a magnetic resonance spectroscopy study Biol Psychiatry 58 2005 724 730 (Pubitemid 41547240)
80. J. Thberge, Y. Al-Semaan, P.C. Williamson, R.S. Menon, R.W.J. Neufeld, and N. Rajakumar Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS Am J Psychiatry 160 2003 2231 2233 (Pubitemid 39619619)
81. J. Thberge, R. Bartha, D.J. Drost, R.S. Menon, A. Malla, and J. Takhar Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers Am J Psychiatry 159 2002 1944 1946 (Pubitemid 35283267)
82. M.A. Thomas, Y. Ke, J. Levitt, R. Caplan, J. Curran, and R. Asarnow Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia J Magn Reson Imaging 8 1998 841 846 (Pubitemid 28357591)
83. T.N. Venkatraman, R.M. Hamer, D.O. Perkins, A.W. Song, J.A. Lieberman, and R.G. Steen Single-voxel 1H PRESS at 4.0 T: Precision and variability of measurements in anterior cingulate and hippocampus NMR Biomed 19 2006 484 491 (Pubitemid 43997767)
84. N. Tunc-Skarka, W. Weber-Fahr, M. Hoerst, A. Meyer-Lindenberg, M. Zink, and G. Ende MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia Neuroimage 48 2009 525 531
85. T. Wobrock, T. Kamer, A. Roy, K. Vogeley, T. Schneider-Axmann, and M. Wagner Reduction of the internal capsule in families affected with schizophrenia Biol Psychiatry 63 2008 65 71 (Pubitemid 350234883)
86. S.J. Wood, M. Yücel, R.M. Wellard, B.J. Harrison, K. Clarke, and A. Fornito Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: A proton magnetic resonance spectroscopy study at 3 T Schizophr Res 94 2007 328 331 (Pubitemid 47039293)
87. H.C. Yamasue, T. Fukui, R. Fukuda, H. Yamada, S. Yamasaki, and N. Kuroki 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia Neuroreport 13 2002 2133 2137 (Pubitemid 36005940)
88. R. Yasukawa, T. Miyaoka, S. Mizuno, T. Inagaki, J. Horiguchi, and K. Oda Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome) Jr Psychiatry Neuroscien Jpn 30 2005 416 422 (Pubitemid 41812488)
89. A. Zabala, J. Snchez-Gonzlez, M. Parellada, D.M. Moreno, S. Reig, and M.T. Burdalo Findings of proton magnetic resonance spectometry in the dorsolateral prefrontal cortex in adolescents with first episodes of psychosis Psychiatry Res Neuroimaging 156 2007 33 42 (Pubitemid 47375071)
90. D.P. Auer, M. Wilke, A. Grabner, J.O. Heidenreich, T. Bronisch, and T.C. Wetter Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation Schizophr Res 52 2001 87 99 (Pubitemid 32947051)
91. S. Bluml, J. Tan, K. Harris, N. Adatia, A. Karme, and T. Sproull Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo J Comput Assist Tomogr 23 1999 272 275 (Pubitemid 29138505)
92. C. Baolu, M. etn,. ner, S. Ebrn,.B. Semz, and H. Kandlcolu Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients Turk J Psychiatry 17 2006
93. R. Bartha, Y.M. Al-Semaan, P.C. Williamson, D.J. Drost, A.K. Malla, and T.J. Carr A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients Biol Psychiatry 45 1999 1403 1411 (Pubitemid 29457551)
94. R.F. Deicken, L. Zhou, N. Schuff, G. Fein, and M.W. Weiner Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy Biol Psychiatry 43 1998 483 488 (Pubitemid 28161292)
95. H. Fukuzako, S. Kodama, T. Fukuzako, K. Yamada, W. Doi, and D. Sato Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy Psychiatry Res 92 1999 45 56 (Pubitemid 29512392)
96. H. Fukuzako Heritability heightens brain metabolite differences in schizophrenia J Neuropsychiatry Clin Neurosci 12 2000 95 97 (Pubitemid 30093696)
97. L.S. Kegeles, D.C. Shungu, S. Anjilvel, S. Chan, S.P. Ellis, and E. Xanthopoulos Hippocampal pathology in schizophrenia: Magnetic resonance imaging and spectroscopy studies Psychiatry Res Neuroimaging 98 2000 163 175 (Pubitemid 30255912)
98. M. Maier, and M.A. Ron Hippocampal age-related changes in schizophrenia: A proton magnetic resonance spectroscopy study Schizophr Res 22 1996 5 17 (Pubitemid 26352770)
99. H.A. Nasrallah, T.E. Skinner, P. Schmalbrock, and P.M. Robitaille Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: A pilot study Br J Psychiatry 165 1994 481 485 (Pubitemid 24305956)
100. H. Scherk, M. Backens, P. Zill, T. Schneider-Axmann, T. Wobrock, and J. Usher SNAP-25 genotype influences NAA/Cho in left hippocampus J Neural Transm 115 2008 1513 1518
101. W. Weber-Fahr, G. Ende, D.F. Braus, P. Bachert, B.J. Soher, and F.A. Henn A fully automated method for tissue segmentation and CSF-Correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia Neuroimage 16 2002 49 60 (Pubitemid 34852472)
102. S.J. Wood, G.E. Berger, R.M. Wellard, T. Proffitt, M. McConchie, and D. Velakoulis A 1H-MRS investigation of the medial temporal lobe in antipsychotic-nave and early-treated first episode psychosis Schizophr Res 102 2008 163 170
103. D.A. Yurgelun-Todd, P.F. Renshaw, S.A. Gruber, C. Waternaux, and B.M. Cohen Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls Schizophr Res 19 1996 55 59 (Pubitemid 26133213)
104. P. Delamillieure, J. Fernandez, J.-M. Constans, P. Brazo, K. Benali, and P. Abadie Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: Preliminary report Am J Psychiatry 157 2000 641 643 (Pubitemid 30191209)
105. G. Ende, D.F. Braus, S. Walter, and F.A. Henn Lower concentration of thalamic N-acetylaspartate in patients with schizophrenia: A replication study Am J Psychiatry 158 2001 1314 1316 (Pubitemid 32717708)
106. A. Jakary, S. Vinogradov, R. Feiwell, and R.F. Deicken N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI Schizophr Res 76 2005 173 185 (Pubitemid 40804764)
107. B. Martnez-Granados, O. Brotons, M.C. Martnez-Bisbal, B. Celda, L. Mart-Bonmati, and E.J. Aguilar Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia Schizophr Res 104 2008 13 22
108. S.Y. Yoo, S. Yeon, C-H. Choi, D-H. Kang, J-M. Lee, and Shin Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus Schizophr Res 111 2009 86 93
109. M.S. Keshavan, D.M. Montrose, J.N. Pierri, E.L. Dick, D. Rosenberg, and L. Talagala Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: Preliminary studies Prog Neuro-Psychopharmacol Biol Psychiatry 21 1997 1285 1295 (Pubitemid 28046701)
110. S.E. Purdon, A. Valiakalayil, C.C. Hanstock, P. Seres, and P. Tibbo Elevated 3T proton MRS glutamate levels associated with poor continuous performance test (CPT-0X) scores and genetic risk for schizophrenia Schizophr Res 99 2008 218 224
111. P. Tibbo, C. Hanstock, A. Valiakalayil, and P. Allen 3-T Proton MRS Investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia Am J Psychiatry 161 2004 1116 1118 (Pubitemid 38736001)
112. K. Aydin, A. Ucok, and S. Cakir Quantitative proton MR spectroscopy findings in the corpus callosum of patients with schizophrenia suggest callosal disconnection AJNR Am J Neuroradiol 28 2007 1968 1974 (Pubitemid 350174744)
113. K. Aydin, A. Ucok, and J. Guler Altered metabolic integrity of corpus callosum among individuals at ultra high risk of schizophrenia and first-episode patients Biol Psychiatry 64 2008 750 757
114. J.R. Bustillo, L.M. Rowland, J. Lauriello, H. Petropoulos, R. Hammond, and B. Hart High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia Am J Psychiatry 159 2002 130 133 (Pubitemid 41070738)
115. R.G. Steen, R.M. Hamer, and J.A. Lieberman Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and Meta-analysis Neuropsychopharmacology 30 2005 1949 1962 (Pubitemid 43093497)
116. J. Theberge, K.E. Williamson, N. Aoyama, D.J. Drost, R. Manchanda, and A.K. Malla Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia Br J Psychiatry 191 2007 325 334 (Pubitemid 47555981)
117. N. Schuff, D.L. Amend, R. Knowlton, D. Norman, G. Fein, and M.W. Weiner Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging Neurobiol Aging 20 1999 279 285 (Pubitemid 29525413)
118. I. Driscoll, D.A. Hamilton, H. Petropoulos, R.A. Yeo, W.M. Brooks, and R.N. Baumgartner The aging hippocampus: Cognitive, biochemical and structural findings Cereb Cortex 13 2003 1344 1351 (Pubitemid 37466781)
119. C.A. Tamminga, A.D. Stan, and A.D. Wagner The hippocampal formation in schizophrenia Am J Psychiatry 167 2010 1178 1193
120. J.E. Lisman, J.T. Coyle, R.W. Green, D.C. Javitt, F.M. Benes, and S. Heckers Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia Trends Neurosci 31 2008 234 242
121. S.A. Schobel, N.M. Lewandowski, C.M. Corcoran, H. Moore, T. Brown, and D. Malaspina Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders Arch Gen Psychiatry 66 2009 938 946
122. G.P. Reynolds, and M.K. Harte The neuronal pathology of schizophrenia: Molecules and mechanisms Biochem Soc Transact 35 2007 433 436 (Pubitemid 46596523)
123. L.S. Pilowsky, R.A. Bressan, J.M. Stone, K. Erlandsson, R.S. Mulligan, and J.H. Krystal First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients Mol Psychiatry 11 2006 118 119 (Pubitemid 43164609)
124. A. Szulc, B. Galinska, E. Tarasow, W. Dzienis, B. Kubas, and B. Konarzewska The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients A proton magnetic resonance spectroscopy (1H MRS) Pharmacopsychiatry 38 2005 214 219 (Pubitemid 41414867)
125. T.K. Rajji, Z. Ismail, and B.H. Mulsant Age at onset and cognition in schizophrenia: meta-analysis Br J Psychiatry 195 2009 286 293
126. C. Mehler, and A. Warnke Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging techniques J Neural Transm 109 2002 219 234 (Pubitemid 34185669)
127. D.F. Braus, G. Ende, W. Weber-Fahr, T. Demirakca, and F.A. Henn Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: An MRSI Study Pharmacopsychiatry 34 2001 251 253 (Pubitemid 33086859)
128. D.F. Braus, G. Ende, W. Weber-Fahr, T. Demirakca, H. Tost, and F.A. Henn Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia Eur Neuropsychopharmacol 12 2002 145 152 (Pubitemid 34168480)
129. A. Bertolino, J.H. Callicott, V.S. Mattay, K.M. Weidenhammer, R. Rakow, and M.F. Egan The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia Biol Psychiatry 49 2001 39 46 (Pubitemid 32332952)